Latest news

BIOPRO's new report entiteld "Healthcare Industry 2018: Facts and Figures for Baden-Württemberg" illustrates key figures of Baden-Württemberg's healthcare industry like number of companies, number of employees and taxable turnover for the biotechnology, medical technology and pharmaceutical industry. In addition, the report highlights key location factors as well as information on company foundations, investments, acquisitions and so forth.

Download (PDF ca. 4.86 MB)

New on ...

... Healthcare industry BW

Retinal diseases such as age-related macular degeneration (AMD) are now treatable. However, it is hard to predict individual disease progression. A group of researchers at the University Eye Centre in Freiburg are currently developing a new system which is hoped will allay fears and improve therapy planning. The system uses artificial intelligence to predict therapeutic outcome from image and patient data. Initial results are already available.

... Healthcare industry BW

Industry has been using enzymes for over a hundred years. While it initially had to content itself with natural enzymes, it is now increasingly possible to design tailor-made biocatalysts with specific properties. The start-up company candidum GmbH from Stuttgart promises to achieve this faster than ever before - mostly thanks to accelerated virtual screening.

... Bioeconomy BW

Wood pulp as well as hemp and flax are renewable raw materials that can be processed into fibres of a new performance class using innovative technologies. They are environmentally friendly and help to solve waste problems. Products and processes for these fibres of the future are being developed at the DITF Denkendorf. They are suitable for textile and technical applications.

... Bioeconomy BW

In the new gene technology report, the interdisciplinary working group of the Berlin-Brandenburg Academy of Sciences (BBAW) takes stock of gene technology developments in Germany during the past few decades, and discusses the societal, legal and ethical challenges associated with these technologies in the future. The report is highly topical due to the controversy surrounding the ruling of the European Court of Justice on CRISPR/Cas9 genome editing.

Event recommendations

Website address: https://www.biofabnet.de/en/